CytomX Therapeutics, Inc. - Laporan Laba Rugi (TTM)

CytomX Therapeutics, Inc.
US ˙ NasdaqGS ˙ US23284F1057

Laporan Laba Rugi (TTM)

Laporan Laba Rugi CytomX Therapeutics, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 92 68 67 66 66 37 30 27 21 53 68 79 95 101 119 120 127 138 148 141
Change (%) -25.84 -2.47 -0.48 -0.30 -43.65 -18.58 -11.31 -23.90 159.26 27.20 17.55 19.17 6.84 17.75 0.33 5.89 9.07 6.85 -4.38
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales
Change (%)
% of Revenue
Gross Operating Profit 92 68 67 66 66 37 30 27 21 53 68 79 95 101 119 120 127 138 148 141
Change (%) -25.84 -2.47 -0.48 -0.30 -43.65 -18.58 -11.31 -23.90 159.26 27.20 17.55 19.17 6.84 17.75 0.33 5.89 9.07 6.85 -4.38
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
SG&A 36 36 36 36 39 39 40 43 42 40 38 34 30 30 30 31 32 30 31 30
Change (%) -0.20 -0.96 2.00 6.73 0.80 3.36 5.82 -1.39 -4.24 -6.34 -11.47 -10.97 0.54 -0.74 3.34 3.70 -6.90 5.63 -5.65
% of Revenue 39.13 52.66 53.47 54.80 58.67 104.95 133.23 158.95 205.98 76.08 56.02 42.19 31.52 29.66 25.00 25.75 25.22 21.52 21.28 21.00
R&D 127 113 92 95 100 114 122 127 129 107 97 87 73 78 79 83 88 83 80 68
Change (%) -11.33 -18.10 2.20 5.39 14.63 7.17 4.13 0.96 -17.19 -8.81 -10.79 -16.06 6.76 1.13 5.73 5.92 -5.22 -3.82 -14.78
% of Revenue 138.04 165.05 138.59 142.32 150.44 306.05 402.82 472.95 627.45 200.42 143.69 109.04 76.81 76.75 65.92 69.46 69.48 60.38 54.35 48.44
OpEx 163 149 128 131 138 153 163 170 171 147 135 120 103 108 108 114 120 113 112 98
Change (%) -8.87 -13.95 2.14 5.76 10.75 6.20 4.55 0.37 -13.99 -8.13 -10.98 -14.64 4.95 0.61 5.07 5.32 -5.67 -1.34 -12.21
% of Revenue 177.17 217.70 192.06 197.12 209.11 411.00 536.05 631.90 833.42 276.50 199.71 151.22 108.32 106.41 90.92 95.21 94.70 81.90 75.63 69.44
Operating Income -71 -81 -61 -65 -72 -116 -132 -143 -150 -94 -67 -41 -8 -6 11 6 7 25 36 43
Change (%) 13.11 -23.72 4.99 12.01 60.61 14.16 8.19 4.93 -37.61 -28.14 -39.61 -80.63 -17.78 -266.96 -47.15 17.27 272.50 43.86 19.93
% of Revenue -77.17 -117.70 -92.06 -97.12 -109.11 -311.00 -436.05 -531.90 -733.42 -176.50 -99.71 -51.22 -8.32 -6.41 9.08 4.79 5.30 18.10 24.37 30.56
Interest Expense
Change (%)
% of Revenue
Net Income -54 -65 -61 -64 -72 -116 -132 -143 -149 -99 -71 -42 -10 -1 17 11 14 32 42 48
Change (%) 20.84 -6.44 5.88 12.26 60.75 14.18 7.75 4.55 -33.36 -28.87 -40.21 -75.90 -94.41 -3,005.62 -32.95 24.75 130.43 30.54 15.34
% of Revenue -58.13 -94.73 -90.87 -96.67 -108.85 -310.54 -435.46 -529.02 -726.77 -186.82 -104.47 -53.13 -10.75 -0.56 13.87 9.27 10.92 23.08 28.19 34.01

Source: Capital IQ

Other Listings
DE:6C1 € 1.76
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista